Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial.
Tamburino C, La Manna A, Di Salvo ME, Sacchetta G, Capodanno D, Mehran R, Dangas G, Corcos T, Prati F. Tamburino C, et al. Among authors: la manna a. JACC Cardiovasc Interv. 2009 Mar;2(3):197-204. doi: 10.1016/j.jcin.2008.12.006. JACC Cardiovasc Interv. 2009. PMID: 19463426 Free article. Clinical Trial.
Optical coherence tomographic results at six-month follow-up evaluation of the CATANIA coronary stent system with nanothin Polyzene-F surface modification (from the Assessment of The LAtest Non-Thrombogenic Angioplasty Stent [ATLANTA] trial).
La Manna A, Capodanno D, Cera M, Di Salvo ME, Sacchetta G, Corcos T, Prati F, Tamburino C. La Manna A, et al. Am J Cardiol. 2009 Jun 1;103(11):1551-5. doi: 10.1016/j.amjcard.2009.01.378. Epub 2009 Apr 8. Am J Cardiol. 2009. PMID: 19463514 Clinical Trial.
ClearWayRX system to reduce intracoronary thrombus in patients with acute coronary syndromes according to optical coherence tomography after abciximab intracoronary local infusion trial (COCTAIL): study rationale and design.
Capodanno D, Prati F, Pawlowsky T, Ramazzotti V, Albertucci J, La Manna A, Robert G, Tamburino C. Capodanno D, et al. Among authors: la manna a. J Cardiovasc Med (Hagerstown). 2010 Feb;11(2):130-6. doi: 10.2459/JCM.0b013e32832e0ae1. J Cardiovasc Med (Hagerstown). 2010. PMID: 19829141 Clinical Trial.
Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation.
Tamburino C, Capranzano P, Capodanno D, Tagliareni F, Biondi-Zoccai G, Sanfilippo A, Caggegi A, Barrano G, Monaco S, Tomasello SD, La Manna A, Di Salvo M, Sheiban I. Tamburino C, et al. Among authors: la manna a. JACC Cardiovasc Interv. 2010 Jun;3(6):624-31. doi: 10.1016/j.jcin.2010.03.016. JACC Cardiovasc Interv. 2010. PMID: 20630455 Free article.
Self-apposing STENTYS® stent in acute myocardial infarction.
Giacchi G, La Manna A, Tamburino C, Capodanno D, Capranzano P, Tamburino C. Giacchi G, et al. Among authors: la manna a. Minerva Cardioangiol. 2014 Feb;62(1):59-70. Minerva Cardioangiol. 2014. PMID: 24500217 Review.
Treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds.
Capranzano P, Gargiulo G, Capodanno D, Longo G, Tamburino C, Ohno Y, Attizzani GF, La Manna A, Di Salvo M, Francaviglia B, Grasso C, Sgroi C, Tamburino C. Capranzano P, et al. Among authors: la manna a. Minerva Cardioangiol. 2014 Jun;62(3):229-34. Minerva Cardioangiol. 2014. PMID: 24831758 Clinical Trial.
360 results